Summary.-An antigenic activity in pleural effusions of patients with squamous-cell carcinoma of the lung has been prepared in highly purified form by a 5-step fractionation scheme. The purified substance, designated LuCA (lung cancer antigen), was assessed during the course of the fractionation procedure by a radioimmunometric assay carried out with specific soluble reagents. Sensitive saturation-binding assays showed no or only weak uptake of the 1251-labelled antigen preparation by a panel of antisera specific for known bronchogenic tumour markers, and for normal human serum proteins. The preparation appeared to contain lung-tumour-associated antigens, one of them probably distinct for squamous-cell carcinomas. The antigen fraction consists of acid-soluble glycoproteins, and was demonstrated by SDSpolyacrylamide gel electrophoresis as a single band in the mol. wt region of 43,000. The gel-filtration elution volume appeared to indicate the occurrence of the antigenic activity in multiples of this smaller unit. Pilot radioimmunoassays performed with LuCA and an absorbed specific antiserum suggest the possible suitability of the marker preparation for screening lung-cancer patients.
THE ISOLATION of soluble tumour-associated antigens from lung tumour tissue has recently been attempted by several laboratories. The degree of antigenic and cancer specificity was usually assessed by immunodiffusion, immunoelectrophoresis, or immunofluorescence, using antisera from which antibodies to contaminants had been removed by absorption. Many of the preparations were not considered to be distinct for tumour tissue or restricted to lung tumours (Yachi et al., 1968; Watson et al., 1975; Granlund & Ritts, 1976; Veltri et al., 1977; Bell et al., 1979; Kempner et al., 1979) whereas others were found at abnormally high concentration in extracts from lung tumours when compared with those from normal lungs (Louis et al., 1973; Frost et al., 1975; Akeson, 1977) . Frost et al. (1975) reported an antigen with a mol. wt of 40,000 which was heat and acid stable to a certain extent and showed cationic mobility. The antigen found by Braatz et al. (1978) had a mol. wt of 77,000 by sedimentation coefficient and a subunit of 42,000 by SDS-polyacrylamide gel electrophoresis.
Only a few preparations to date have been tested in radioimmunoassays for lung cancer antigens (cf. Herberman, 1979) . One of us has described a semi-purified glycoprotein with tumour-associated characteristics (Wolf, 1978) which has now been highly purified and used as labelled antigen in radioimmunoassays for the screening of patients' sera. In the following, we present the purification procedure of this antigen, and results from discrimination and specificity experiments as well as from radioimmunoassays.
MATERIALS AND METHODS
Pleural effusions and patients' sera.-Pleural effusions withdrawn by sterile puncture were obtained from Lainz Hospital, Vienna. Cells were removed by centrifugation, and the clear supernatant fluid was stored at -20TC until use. Sera from malig-nant patients and from healthy individuals were also obtained by courtesy of Lainz Hospital.
Production of antisera.-Fifteen rabbits were injected with various materials: (a) with minced tissue from normal lungs removed at the time of a postmortem examination; (b) with crude or purified fractions prepared from pleural exudates of patients with squamous-cell carcinoma of the lung, designated "specific antisera"; (c) with a fraction comparable to (b) but derived from normal human serum. In the case of solid material, packed volumes of 0-2 to 0 5 ml were injected, first i.m. then i.v., and finally i.d., at weekly intervals. The animals were bled 6 weeks after the initial injection, and bled out shortly thereafter when the antibody titre was satisfactory. In the case of soluble fractions, 20-200 ,ug protein (depending on the availability of material), emulsified in Freund's Complete Adjuvant, was injected i.d. at 3 sites on the animal's flanks. The injections were repeated 4 weeks later with Freund's Incomplete Adjuvant, and the animals were bled 6 weeks after the start of immunization. If the resulting antiserum showed a titre after absorption, injections were repeated at intervals of one month. Saturation-binding assays demonstrated that the titre of absorbed specific antisera increased gradually with the purification stage of the preparation used for immunization.
Commercial antisera.-Twelve antisera were purchased from either Dako-Immunoglobulins, Copenhagen, or from Nordic Immunology, Holland (details in Table III) .
Absorption of antisera.-Small amounts of antisera were incubated in equal volumes, first with cross-linked normal human serum (Avrameas & Ternynck, 1969) for 15 min at room temperature, and after thorough shaking for a further 15 min at 4°C. The same procedure was used for the absorption with normal lung tissue.
Ion exchange chromatography.-A pleural effusion containing 20 mg protein per ml was applied to a column (15*0 x 16 cm) of DEAE-Sephacel (Pharmacia) equilibrated with Tris/HC1 buffer (01M, pH 6.5). Elution was carried out in steps, using initially the same buffer and subsequently adding NaCl of increasing molarity from 0dIM to 0-5M. Peak fractions were pooled, dialysed against phosphate-buffered saline (O15M NaCl in phosphate buffer, O0O1M, pH 7.2) and concentrated with polyethylene glycol 20,000. These and all further chromatographic manipulations were carried out at 4°C. Affinity chromatography.-Two ml of the active DEAE fraction containing between 15 and 50 mg protein was applied to a column (12-0 x I 0 cm) of concanavalin ASepharose (Pharmacia) equilibrated with phosphate-buffered saline (PBS). Elution of the bound material was accomplished by a-methyl-D-glucopyranoside (50 mm), and after dialysis in PBS and concentration a volume of this fraction, containing 2-4 mg protein, was applied to a column (5.0 x I 0 cm) of wheat-germ lectin-Sepharose (Pharmacia), equilibrated with PBS. The bound protein was eluted by N-acetyl-D-glucosamine (100 mg/ml) in PBS. Fractions were pooled, dialysed, and concentrated.
Gel-filtration chromatography.-For a separation, 1-2 ml (containing 1-2 mg protein of the material eluted by glucosamine from the wheat-germ lectin-Sepharose column) was filtered by upward flow through a column (100 0 x 1 0 cm) of Sephacryl S 300 Superfine (Pharmacia), equilibrated with 0-4M NaCl in phosphate buffer, pH 8-0, 0-05M. Elution was carried out with the same buffered NaCl (flow rate 15 ml/h). To a separation of unlabelled fractions an amount of , 105 ct/min of a 1251I-labelled antigen preparation was added as tracer. When radio-labelled material was chromatographed a total of 10-15 x 106 counts per min was applied to the column.
Absorption of purified fractions.-This was performed with a cross-linked anti-humanserum antiserum. Small amounts of antigen preparations (0.3-0.5 ml) were incubated at equal volumes with the solidified antiserum for 15 min in the cold. After centrifugations the supernatant was further processed.
Preparation of 125I-antigen.-Labelling with Na 1251 (Radiochemical Centre, Amersham) was carried out using the Chloramine-T method (Hunter, 1974) with slight modifications. Between 5 and 20 ,ug protein was labelled at a time, and a small Sephadex G-15 column, equilibrated with PBS, was used to separate the labelled protein from the free 125iodide. Peak fractions of labelled protein (sp. act. 10-20 HCi/,ug protein) were further purified on a Sephacryl S 300 column as described above.
Saturation-binding assay.-This method, measuring the rate of antigen uptake by antiserum (Ratcliffe, 1974) , was used to determine the titre of antisera, or to obtain a criterion for pooling and assessing 1251-antigen fractions. Tests were performed with PBS (pH 7.2) as diluent, but antiserum concentrations of 1: 10,000 and less were made up in normal rabbit serum diluted 1:20. For defining an antiserum titre, 10 1ul (s 8000 ets/min) of a known labelled antigen fraction was pipetted into conical plastic tubes (Sarstedt GmbH, 0 75 ml) which had been rinsed with 0.15% bovine serum albumin (BSA). This was followed by the addition of 50 ,ul of the unknown antiserum at 3-fold serial dilutions starting at the concentration 1:20. After mixing, the tubes were counted in an Auto Gamma Scintillation Spectrometer (Packard) and left overnight at 4°C. Tests were set up in duplicate, including background (BG) tubes containing labelled antigen and PBS only. Next day 100 pl goat anti-rabbit antiserum (second antibody) was added, and the tubes were left for another 3 h at 4°C. They were then centrifuged on an Eppendorf Microfuge at 10,000 rev/min for 5 min in order to separate the bound from the free label. The supernatant was carefully removed and the tubes counted again. To assess unknown labelled fractions from column separations, and to determine the specificity of LuCA preparations, the method was the same except that known antisera were used. For both purposes the percent of bound label precipitated in the tube (B) was determined for each tube from the original total label (T) and from this the mean percentage of the duplicate tubes was calculated. The rate of uptake was then expressed as B/T (sample) minus B/T (BG) =percentage uptake.
Monitoring the antigenic activity.-The relative antigenic activity of unlabelled chromatographic fractions was assessed by a competitive radioimmunometric assay, measuring the inhibition of radio-labelled antigen uptake by an absorbed specific antiserum. Unknown unlabelled fractions were serially diluted in PBS (pH 7.2) and 10 ,u of each dilution was pipetted into conical tubes rinsed with BSA. Ten ,ul of a labelled antigen ( 8000 cts/min) was added, followed by 50 ,lI of absorbed specific antiserum diluted as judged by titration curves. Control tubes contained label, antiserum and PBS only. After mixing, the tubes were incubated in the cold for 72 h. All further manipulations were carried out as described for the saturationbinding assay. Tests were set up in duplicate or triplicate, and for each sample dilution the mean percentage uptake was calculated as above. Inhibition was expressed as:
Only those fractions which gave the greatest inhibition were further processed. The sensitivity limit of this assay as performed with semi-purified reagents was 100 ng protein/ml. An example of monitoring the activity during the course of purification is given in Fig. 1 . Radioimmunoassay.-Essentially the same technique was used as for the radioimmunometric assay, except that a 20% solution of polyethylene glycol 6000 was substituted for the second antibody (Grudzinskas et al., 1977) . After standing at 4°C for 72 h and the assay. The fractions were eluted from chromatographic columns in the course of the purification of preparation A/66. Pools II (a) and II (b) together constitute the peak material eluted by 0-2M NaCl from a DEAE-Sephacel column. Pools I and III were eluted by 0IM NaCl and 0-4M NaCl respectively. CON A= an absorbed fraction of a Coneanavalin A-Sepharose column. WGL=an absorbed fraction of a wheatgerm lectin-Sepharose column. 0 fractions assayed at 100 ,ug/ml; 0 Fractions assayed at 10 ,ug/ml. The absorbed specific antiserum had been raised with Peak B material ( Fig. 3(a) ) and was used in the assay 1:500 diluted in PBS (pH 7.2). The labelled antigen corresponds to material marked "Pool" in Fig. 3(b) . Note the relative increase in inhibitory activity with progressing purification of the fractions. 104 cts/min/ sample was applied to the gel. After electrophoresis the gel was covered with a thin plastic foil and, without drying, exposed to a Kodak X-Omat R film for 24 h using an intensifying screen (Kodak) to enhance autoradiography. Mol. wt markers included cytochrome C (12,000), ovalbumin (43,000), human serum albumin (68,000), human IgG purified by an affinity column of protein ASepharose (160,000) and ferritin (550,000). Markers were labelled with 1 251 for autoradiography.
RESULTS
Preparation of the marker Fig. 2 shows the essential stages of the purification. The final preparation was termed lung-carcinoma antigen (LuCA) and represented less than 1/105 of the protein in the starting material. The iodinated fractions were only roughly judged for protein by calculation from the labelling efficiency, since the protein content was immeasurably low. PLEURAL (see Fig. 3 (e)) Details of the ion-exchange and affinity columns have previously been given (Wolf, 1978) . Briefly, the most active antigenic material was found in the fraction eluted by 0-2M NaCl from DEAESephacel, and in the fractions found by both Con A and wheat-germ lectinSepharose.
The relevant sections of the gel-filtration profiles from 3 consecutive Sephacryl S-300 columns are depicted in Fig. 3 glycoprotein. When Peak B material was labelled and re-chromatographed on Sephacryl (Fig. 3b ) the specific antigenic activity was found in the ascending part of Peak D. Since on this column it did not clearly separate from the total peak, an additional purification step was introduced. Concentrated unlabelled Peak B material was submitted to absorption with an antiserum to normal human serum. It was then iodinated and, by re-chromatography, separated clearly into 3 peaks (Fig. 3c) . Single fractions of these peaks were tested in saturation-binding assays with 4 different antisera, as shown in Table II . The results indicated that Peak E contained normal lung proteins, whereas the intermediate Peak F was made up of the pertinent antigenic material showing a high specific activity, and being slightly contaminated by substances of the adjacent peaks. Peak G proved to consist chiefly of normal serum proteins, including small amounts of the specific lungcancer material. Fractions of Peak F were TABLE II.-Antigenic discrimination of single fractions from Sephacryl S 300 column by saturation assay with 4 antisera diluted 1:10,000* Antiserum to Pleural effusion fraction (xi-Acid glycoprotein Normal human serum proteins Normal human lung % Maximal uptake of numbered 125I-fractions (Fig. 3(c) Fig. 3(a) ) not absorbed; d = Peak B material absorbed with antiserum to normal human serum; e = Peak F material (Fig. 3(c) ) designated "LuCA"; f=Peak G material (Fig. 3(c) ) found to be chiefly (xi-acid glycoprotein. serum to normal human serum, removed contaminants rather effectively, though not completely, from the unlabelled antigen preparation. On the other hand, the labelled LuCA sample appears to be homogeneous. Both labelled and unlabelled LuCA samples formed a band in a position close to ovalbumin thus exhibiting, under the given reducing conditions, a mol. wt of -43,000. By gel filtration, however, both preparations appeared in fractions eluting from the column before human serum albumin suggesting a mol. wt > 68,000. There was no difference by electrophoresis in the position of LuCA and al1-acid glycoprotein, though from gel columns the 2 substances clearly eluted in different but partly overlapping peaks (cf. Fig. 3c and Table II) . 1: 20,000
1: 5000 * All antisera produced in the rabbit, apart from that to human serum, which was produced in the pig.
t Commercial firms from which purchased.
Relationship of LuCA to known markers and normal serum components Since there are several nonspecific markers of bronchogenic cancers (cf. review Coombes et al., 1978 ) the crossreactivity of LuCA was checked by saturation binding assays with a panel of 14 antisera. Table III shows that antisera to the known markers ferritin, lactoferrin, and /32-microglobulin, did not take up LuCA at all. Four other antisera directed to a,-acid glycoprotein, carcinoembryonic antigen (CEA), al-antichymotrypsin, and pregnancy-specific 1i-glycoprotein exhibited low titres of 1: 20, 1: 60, 1 :100 and 1:100 respectively. LuCA does not appear to be one of these markers, but it may react nonspecifically with some antisera at a low level. Similar observations were made when antisera raised to normal lung tissue or to normal serum components were assayed. The highest titre obtained was 1: 320 by anti-normal lung serum and anti-Ac2-macroglobulin serum. However, the titre of the absorbed specific antiserum was 1: 5000 when diluted in PBS, thus exhibiting a discrimination factor of more than 15.
Estimation of specific LuCA in serum samples by radioimmunoassay Assays were performed with a LuCA preparation as labelled antigen, a Peak B preparation as standard, and an absorbed antiserum which had been raised with Peak B fractions. This antiserum exhibited a maximal LuCA uptake of 80%, and was used in the present assays at 1: 50,000 diluted in 20% normal rabbit serum.
In order to estimate the antigen content of serum samples, a standard doseresponse curve was produced with serial dilutions of Peak B material. Fig. 5 shows that the assay has a lower limit of -10 ng/ ml, and a working range of up to 5 ,ug/ 40 -20I U ) 10-ml. Estimates above 400 ng/ml have a relatively wide scatter.
Untreated test sera frequently gave paradoxical results showing low, or nc inhibition of label uptake when used undiluted, and increasing inhibition when serially diluted. As this pointed to an interfering factor in whole serum, samples were extracted with perchloric acid, which leaves a certain type of glycoprotein in solution while precipitating the bulk of normal proteins (Hakim, 1980) . After incubation the samples were cleared by centrifugation, and the supernatant was dialysed for 36 h against PBS (pH 7.8) with 2 changes of the buffer. For assays used the supernatant samples were used, either non-diluted or diluted 1:10. As a routine each assay series included several dilutions of a standard preparation. The The present marker preparation "LuCA", isolated from malignant pleural effusions of patients with squamous-cell carcinoma of the lung by a 5-step purification procedure, exhibited antigenic properties in common with fractions prepared in a similar fashion from lung-tumour extracts in our laboratory (cf. Wolf, 1978 It cannot be established at present whether the main component of LuCA is a genuine neoantigen expressed on the surface or in the cytoplasm of the tumour cell, or whether it is a product induced by the spreading malignant growth. In any case, in radioimmunoassays LuCA seems to be preferentially replaced by substances in lung-cancer sera, but not in normal sera.
The presented radioimmunoassays are pilot experiments on a small scale. They allow only preliminary conclusions about 27i4 the usefulness of the developed test. The assay system responds particularly well to sera from patients with squamous-cell carcinoma of the lung which appears to prove a certain degree of specificity. But the evidence from assays with sera from other histological types of lung cancer suggest that there may be several antigens involved in the system, one possibly distinct for squamous-cell carcinomas, and others perhaps common to various histological types of lung cancer. To judge, on the other hand, by the different antigen contents in sera from early and late stages of squamous-cell carcinoma, and from the cross-reactivity of sera from patients with unrelated metastatic tumours, one might even speculate that the assay system recognizes an antigen which is characteristic for lung metastases of various origin. But the data suggest that a LuCA-like substance occurs in primary lesions too, though probably at a low level.
In some patients the antigen concentration in the serum was found to have fallen appreciably after surgery (results unpublished) and assays are now in progress to follow up such fluctuations in a greater number of sera and in relation to the clinical status of the patient. This may then provide further information on the suitability of the marker preparation for screening purposes.
